Safety of benzodiazepines in newborns

Annals of Pharmacotherapy

Volumn 36, Issue 7-8, 2002, Pages 1150-1155

  Ng, Eugene ^a   Klinger, Gil ^a   Shah, Vibhuti ^a   Taddio, Anna ^a   Pérez, Annette ^a   Gagnon, Louise ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Benzodiazepines; Lorazepam; Midazolam; Neonates

Indexed keywords

ANALGESIC AGENT; BENZODIAZEPINE DERIVATIVE; IPRATROPIUM BROMIDE; LORAZEPAM; MIDAZOLAM; MILRINONE; MORPHINE; PHENOBARBITAL; PHENYTOIN; SALBUTAMOL; VANCOMYCIN;

ANALGESIA; ANTICONVULSANT THERAPY; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG SAFETY; FEMALE; GESTATIONAL AGE; HUMAN; HYPOTENSION; INCIDENCE; INFANT; INOTROPISM; MAJOR CLINICAL STUDY; MALE; NEWBORN DISEASE; POLYPHARMACY; POSTNATAL DEVELOPMENT; PREMATURITY; PRIORITY JOURNAL; RESPIRATION DEPRESSION; RISK BENEFIT ANALYSIS; SCORING SYSTEM; SEDATION; SEIZURE; STATISTICAL SIGNIFICANCE; NEWBORN; RETROSPECTIVE STUDY;

BENZODIAZEPINES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; LORAZEPAM; MALE; MIDAZOLAM; RETROSPECTIVE STUDIES; SEIZURES;

EID: 0036020154     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A328     Document Type: Article

References (27)

1. A cross-sectional survey of pain and pharmacological analgesia in Canadian neonatal intensive care units
2. Clinical pharmacokinetics of sedatives in neonates
3. Analgesia and sedation in preterm neonates who require ventilatory support - Result from the NOPAIN trial
4. Placebo-controlled trial of midazolam sedation in mechanically ventilated newborn babies
5. Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit (Cochrane Review)
6. A series of neonatal patients with paradoxical seizure-like reactions to bolus intravenous injections of midazolam
7. Reversible neurologic abnormalities associated with prolonged intravenous midazolam and fentanyl administration
8. Clonic movements following lorazepam administration in full-term infants
9. Resedation after bolus administration of midazolam to an infant and its reversal by flumazenil
10. Neurotoxicity of lorazepam in a premature infant
11. Myoclonus associated with lorazepam therapy in very-low-birth-weight infants
12. Midazolam and myoclonus in neonate
13. Lorazepam toxicity in a premature infant
14. Stereotypic movements after lorazepam administration in premature neonates: A series and review of the literature
15. The use of midazolam in the preterm neonate
16. Myoclonic movements in very-low-birth-weight premature infants associated with midazolam intravenous bolus administration
17. Flumazenil's reversal of myocloniclike movements associated with midazolam in term newborns
18. Epileptic manifestations induced by midazolam in the neonatal period
19. Hypotension with midazolam and fentanyl in the newborn
20. Systolic blood pressure in babies of less than 32 weeks gestation in the first year of life
21. Bronchospasm during inhalation of nebulized midazolam
22. A method of estimating the probability of adverse drug reactions
23. Characterization and classification of neonatal seizures
24. A receptor subunit composition
25. Haemodynamic responses and population pharmacokinetics of midazolam following administration to ventilated, preterm neonates
26. Comparison of the effect of midazolam or vecuronium on blood pressure and cerebral blood flow velocity in the premature newborn
27. 2+